Skip to main content
BioTechnologia logoLink to BioTechnologia
. 2024 Mar 29;105(1):55–68. doi: 10.5114/bta.2024.135642

Phytochemical characterization by GC-MS and in vitro evaluation of antiproliferative and antimigratory studies of Leucas aspera leaf extracts on MDA-MB-231 cell line

Mahaboob Begum SM Fazeela 1,*, Megasri Sankarram 1
PMCID: PMC11020152  PMID: 38633889

Abstract

Breast cancer is the most recurrently identified and one of women’s prominent causes of death. Currently, researchers have turned their focus on natural chemicals from synthetic chemicals due to their environmental, economic, and health benefits. Considering this, the medicinal plant Leucas aspera was chosen for the current study. The aim of this study was to isolate and characterize secondary metabolites from L. aspera and determine the antiproliferative and antimigratory activities in the MDA-MB-231 cell line under in vitro conditions. Phytochemicals from L. aspera were isolated through sequential extraction using hexane, dichloromethane, and ethyl acetate. These extracts were qualitatively screened, subjected to FT-IR, and analyzed using GC-MS. The antiproliferative activity was determined through the MTT assay. Scratch assay was utilized to determine the antimigratory activity of the plant extracts. The phytochemical analysis revealed the presence of steroids, alkaloids, phenols, flavonoids, galactose, tannins, saponins, and amino acids in the extracts. The results of the cell viability assay indicated that the crude dichloromethane and ethyl acetate extracts inhibited cell proliferation, with inhibitory concentrations of 5 and 3 μg/ml, respectively. In contrast, the crude hexane extract did not exhibit any cytotoxicity. Furthermore, the scratch assay results showed that the plant extracts had cell migration inhibitory properties. The outcomes of the current study conclude that L. aspera possesses active therapeutic agents with strong anticancer potential, effectively impeding the proliferation and invasion of MDA-MB-231. Further studies are needed to identify the potential active agents that contribute to these activities.

Keywords: cytotoxic activity, MDA-MB-231, breast cancer, Leucas aspera, anti-migratory efficiency

Introduction

The human body is made up of numerous cells. Usually, when cells mature and get damaged, they need new cells to replace them. This replacement is done by the process of cell division where a cell grows and multiplies. However, when this process becomes deregulated, abnormal cell growth and multiplication may leading to the formation of tumors. These tumors can be either benign or cancerous (malignant). Cancerous tumors undergo a process called metastasis, where the tumors metastasize neighboring tissues and can migrate to distant places to form secondary tumors (World Health Organization, 2021).

Breast cancer is considered as second most common cancer among women. It originates in the epithelial cells lining the ducts and lobules of the breast’s glandular tissue (National Cancer Institute, 2021). According to the World Health Organization, in 2020, approximately 2.3 million new cases of breast cancer were diagnosed globally, resulting in 685,000 reported breast cancer deaths were reported worldwide (World Health Organization, 2021). In India, 26.3% of the female population was affected by breast cancer in 2020, with 90 408 deaths among 178 361 new cases (International Agency for Research on Cancer, 2021). Globally, the incidence of breast cancer is increasing rapidly making females more vulnerable. It accounts for 23% of total cancer cases among females (Global Cancer Observatory, 2021). In many developed countries like the United States, United Kingdom, Australia, and Canada, the mortality rate of cancer has been declining with advancements and refinement in diagnostic techniques and treatment methods, despite the fact breast cancer seems to be the leading cause of cancer death in females (National Cancer Institute, 2021). Among the various types of breast cancer, triple-negative breast cancer (TNBC) accounts for 10–20% of cases. TNBC is a heterogenous tumor where the cancer cells lack estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 gene (HER2) amplification (Kumar and Aggarwal, 2016).

Normal cell division and DNA segregation are regulated by cell cycle checkpoints. The control of cell cycle checkpoints and DNA repair is done by BReast CAncer gene 1 (BRCA1) which acts as a tumor suppressor gene. In breast cancer cells this BRCA1 gene is mutated therefore it cannot repress the estrogen receptor α (ER-α) resulting in the development of TNBC (Sengodan et al., 2018). This mutation indirectly promotes the carcinogenesis of other genes by increasing their mutation rate (Lin et al., 2022).

Treatment options for TNBC, are limited, as hormonal therapy is ineffective due to the absence of ER, PR, and HER2 receptors. So, surgery and chemotherapy are the only ways to treat TNBC (Wahba and El-Hadaad, 2015). Despite being more aggressive, the surgical decision relies on the clinicopathological variables and patient’ preferences. Traditionally radiation therapy has been given to TNBC which is followed by mastectomy or conservative breast surgery (CBS). It is said that CBS followed by radiation-based therapy is equivalent to mastectomy, now this procedure remains a controversy (Al-Mahmood et al., 2018). Chemotherapy is best suggested to treat TNBC to target the DNA repair complex, p53, and cell proliferation (Chen et al., 2021). Adjuvant-based chemotherapy can be more effective in signaling the DNA repair process, but this has not been confirmed in stage III studies (Polley et al., 2021). Moreover, chemotherapy has also shown a few side effects which include nausea, vomiting, fatigue, hair loss, bruising, and bleeding (Centre for Disease Control and Prevention, 2022). Since TNBC is a very uncommon subtype of breast cancer, drugs for standard treatment are not yet available (American Cancer Society, 2022).

Due to many challenges associated with cancer treatment, researchers have redirected their attention towards natural therapies, exploring plant-derived products in the hope of mitigating adverse side effects. Despite the promising anticancer properties, exhibited by certain plant-derived products in preclinical studies, their evaluation in human subjects is still pending (Desai et al., 2008). From ancient civilizations, indigenous plants have been used as alternatives to treat diseases. Recent studies showed that nearly 65% of anticancer drugs are derived from natural compounds that were isolated from plants (Mbele et al., 2017).

One such medicinal plant under scrutiny is Leucas aspera (Family: Lamiaceae, Order: Tubiflorae ), commonly known as “Thumbai”. This annual, branched herb, reaching heights of 15–60 cm, is widely distributed throughout India (Prajapati, 2010). The plant has been used in traditional medicinal systems such as Ayurveda and Siddha. L. aspera has been previously studied for its diverse medicinal properties, including antihistaminic, antipyretic, antifungal, antimicrobial, and antioxidant attributes (Nirmala and Kanchana, 2018; Vasudha et al., 2019; Kumar and James 2020; Mishra et al., 2022). With its extensive medicinal properties, L. aspera is believed to have various active phytochemicals with anticancer properties, as suggested by prior studies (Latha et al., 2013).

Despite these indications, the effect of bioactive molecules from L.aspera and their activity has not yet been studied in TNBC cell line MDA-MB-231. Our current study focused on discovering the active therapeutic agents present in L. aspera and assessing their cytotoxic and antimigratory activities on the MDA-MB-231 cell line under in vitro conditions.

Materials and methods

Collection of plant material

The powdered L. aspera leaves were obtained from Annai Aravindh Herbals in Chennai, India. This identical powdered leaf form was used for both identifying phytochemical components and conducting in vitro evaluation of the antiproliferative and antimigratory properties of L. aspera.

Extraction of phytochemicals from Leucas aspera

Extraction of the plant’s phytochemicals was carried out by sequential method as outlined in the published protocol (Begum et al., 2018). Thirty grams of plant leaf powder underwent extraction with 100 ml of solvents in increasing order of polarity: hexane, followed by dichloromethane, and finally, ethyl acetate. The extraction process took place in an orbital shaker over 72 h. Subsequently, the extract was filtered using Whatman filter paper No: 1 (Sigma – Aldrich), and the filtrate was subjected to evaporation in a rotary evaporator. The resulting dried extracts were stored at 4˚C in storage vials for future studies. This extraction procedure was performed twice, and the extracts were collected following the aforementioned steps.

Phytochemical analysis of Leucas aspera crude extracts

Analysis of phytoconstituents in the crude plant extracts was performed as per standard protocols (Sharma et al., 2021) for alkaloids, flavonoids, tannins, saponins, glycosides, and terpenoids.

Fourier Transform Infrared (FT-IR) spectrometry

To determine various bioactive functional groups within the extracts, FT-IR spectrometry analysis was performed. The dried crude extracts of hexane, dichloromethane, and ethyl acetate of L. aspera were dissolved in methanol (1 mg/ml) and subjected to FT-IR analysis which was based on attenuated total reflection (ATR) (Kumar and Ramaswamy, 2014). This method is based on internal reflection within an optical sensor material. The FT-IR spectrum intensity depends on the number of reflections, the number of molecules of interest and their absorptivity, and the depth of penetration into the sample. The functional group present in each extract was studied using the IR spectrum obtained with 4/cm resolution after 25 scans.

GC-MS analysis of Leucas aspera

The crude hexane, dichloromethane, and ethyl acetate extracts of L. aspera were analyzed in GCMSQP2010 Plus to identify the functional groups present in the extracts. The column temperature was set 45˚C, the injection temperature at 280˚C, the ion source temperature at 250˚C, and the interface temperature at 260˚C. The pressure was maintained at 51.5 kPa, the total flow volume at 54 ml/min, and the solvent cut time was set to 2 min (Konappa et al., 2020). The sample, dissolved in methanol (1 : 10 split ratio), was injected with a volume of 1 μl. Utilizing the mass spectrum generated, a NIST library search was conducted to identify the phytocompounds present in the extracts.

Cell line and cell culture

MDA-MB-231 cells were generously provided by Dr. P. Ashok Kumar from the School of Life Sciences at B.S. Abdur Rahman Crescent Institute of Science and Technology, Chennai, India, and were used in the study. The cells were subcultured in DMEM (high glucose) (HiMedia, USA), supplemented with 10% fetal bovine serum (HiMedia, USA), and 1% antibiotic cocktail (HiMedia, USA). Cultivation of the cells took place in an atmosphere with 5% carbon dioxide at 37˚C. Actively dividing cells were used for further analysis.

Evaluation of cell cytotoxicity of Leucas aspera extracts

The cytotoxic effects of L. aspera extracts were evaluated using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, which involves the reduction of MTT to generate formazan crystals (Dubey et al., 2022). MDA-MB-231 cells were subcultured in DMEM (high glucose), supplemented with 10% FBS and 1% antibiotic cocktail (penicillin G, streptomycin, and fungizone) (HiMedia, USA), and seeded at a density of 1 × 105 cells/well in a 96-well tissue culture plate. The cells were then treated with increasing concentrations of hexane, dichloromethane, and ethyl acetate extracts of L. aspera in triplicate, followed by incubation for 24 h at 37˚C. Subsequently, MTT reagent was added to each well and incubated for 2 h at 37˚C. After 2 h, the formazan crystals were solubilized in isopropanol and incubated at room temperature for 20 min. Untreated cells served as controls. Absorbance was measured at 570 nm using a multimode plate reader. The experiment was conducted in triplicate, and the percentage of cell viability was calculated using the formula:

% Cell viability =Average absorbance of treated cellsAverage absorbance of control×100

Doxorubicin served as the standard reference. Subsequently, to understand alterations in cellular morphology, the cells were exposed to the inhibitory concentration (IC50) of both dichloromethane (5 μg/ml) and ethyl acetate (3 μg/ml) extracts of L. aspera and incubated for 24 h. The morphological changes in treated and control cells were observed under a microscope at 0 and 24 h. The experiment was conducted in triplicate and repeated three times. As the hexane extract did not exhibit toxicity in MDA-MB 231 cells, it was excluded from further studies.

Scratch assay

The anti-invasion effects of L. aspera extract on cell migration were assessed using the migration/scratch assay (Hobani, 2022). Actively dividing MDA-MB-231 cells (1 × 105 cells/well) were subcultured in 6-well tissue culture plates until reaching 70% confluence. A wound was created on the cell monolayer by scratching with a 200 μl micropipette tip. Detached cells were washed and removed with PBS. Subsequently, the cells were treated with serum-free DMEM (high glucose) medium containing dichloromethane (3 μg/ml) and ethyl acetate extracts (2 μg/ml) of L. aspera for 24 h. Cell migration within the wound was determined through imaging at 0 and 24 h. Cells without any treatment served as the control. The experiment was conducted in triplicate, and the results were recorded.

% Cell migration =Number cells migrated in extract treated wellNumber of cells migrated in control×100

Statistical analysis

All the experiments were carried out thrice in triplicate. The values expressed are mean ± SD. IBN SPSS 23 Student t-test was used to determine the level of significance.

Results and discussion

The extracts obtained through sequential extraction with different solvents, following the polarity order: hexane < dichloromethane < ethyl acetate, resulted in dry weights of 0.40, 0.36, and 0.06 g, respectively, after evaporation. Extraction plays a crucial role in separating soluble plant metabolites, with separation occurring based on the solubility of compounds, as solvents of increasing polarity were utilized. Earlier studies have demonstrated that sequential extraction with solvents of varying polarity enhances the extraction of phytocompounds (John et al., 2018). Phytochemical screening of crude extracts of L. aspera indicated the presence or absence of various compounds such as alkaloids, saponins, flavonoids, glycosides, tannins, and terpenoids (Table 1). The order of active phytochemicals was hexane < dichloromethane < ethyl acetate extracts. The results showed that with increasing polarity, the number of extracted phytochemicals also increased. For instance, the hexane extract lacked saponins, flavonoids, and proteins, but these phytochemicals were observed in both dichloromethane and ethyl acetate extracts of L. aspera as polarity increased. These findings can be compared with previous research where methanol and hexane extracts of Leucas aspera were reported to contain saponins, flavonoids, tannins, alkaloids, carbohydrates, and cholesterol (Vasudha et al., 2019). However, the current study did not reveal the presence of carbohydrates and cholesterol in the extracts, possibly due to differences in solvent polarity and extraction methods.

Table 1.

Qualitative analysis of the phytochemicals of Leucas aspera

Phytochemical constituents Hexane Dichloromethane Ethyl acetate
Alkaloids + + +
Saponins - + +
Flavonoids - + +
Glycosides + + +
Tannins + + +
Terpenoids + + +
Carbohydrates - - -
Protein - + +
Resins - - -

(+) – presence, (–) – absence

Previous reports have highlighted the high anticancer effects of flavonoids, including cell cycle arrest, induction of apoptosis, and the suppression of cell proliferation and migration (Kopustinskiene et al., 2020). Alkaloids, on the other hand, are considered natural antioxidants and may act as cancer chemopreventive agents (Cui et al., 2006; Vasudha et al., 2019). Saponins and tannins, identified in the extracts of L. aspera, are highly active phytocompounds. Saponins hinder the DNA replication process, thereby inhibiting cancer cell proliferation and demonstrating antiproliferative activity. Tannins also exhibit high apoptotic activity (Yildirim and Kutlu, 2015). These diverse phytoconstituents present in the extracts of L. aspera may contribute to its biological activity.

The FT-IR analysis of the hexane extract of L. aspera revealed distinctive peaks indicative of various functional groups: C–H stretching of alkane (2914.44/cm), O–H stretching of alcohol (2850.79/cm), C=O stretching of aliphatic ketone (1708.93/cm), C–H bending of alkane-methyl group (1452.40/cm), CN stretching of aromatic amine (1367.53/cm), CO stretching of ester (1172.72/cm), C=C bending of alkene (970.19/cm), and C=C bending of alkene (725.56/cm) in the extract. The FTIR spectra are given in (Fig. 1) and the functional groups identified are given in Table 2.

Fig. 1.

Fig. 1

FTIR profile of hexane extract of Leucas aspera

Table 2.

Functional groups identified with FT-IR analysis in hexane extract of L. aspera

S. No. Peak Compound class Group
1 725.56 alkene C=C bending
2 970.19 alkene C=C bending
3 1172.72 esther C=O stretching
4 1367.53 aromatic amine C–N stretching
5 1452.40 alkane-methyl group C–H bending
6 1708.93 aliphatic ketone C=O stretching
7 2850.79 alcohol O–H stretching
8 2914.44 alkane C–H stretching

The FT-IR analysis of the dichloromethane extract of L. aspera, revealed characteristic peaks representing different functional groups: C–O stretching of ester (1166.93/cm), C–O stretching of aromatic ester (1276.88/cm), C–N stretching of aromatic amine (1373.32/cm), O–H stretching of alcohol (2854.65/cm), O–H stretching of carboxylic acid (2922.16/cm), C=O stretching of aliphatic ketone (1708.93/cm), N–H bending of amine (1604.77/cm), N–O stretching of nitro compounds (1514.12/cm), C–H bending of benzene derivatives (713.66/cm), and C=C bending of trisubstituted alkanes (848.68/cm) was revealed (Fig. 2, Table 3).

Fig. 2.

Fig. 2

FTIR profile of dichloromethane extract of L. aspera

Table 3.

Functional groups identified with FT-IR analysis in dichloromethane extract of L. aspera

S. No. Peak Compound class Group
1 713.66 benzene derivative C–H bending
2 848.68 alkane-trisubstituted C=C bending
3 1105.21 amine C–N stretching
4 1166.93 ester C–O stretching
5 1276.88 aromatic ester C–O stretching
6 1373.32 aromatic amine C–N stretching
7 1450.47 alkane-methyl group C–H bending
8 1514.12 nitro compound N–O stretching
9 1604.77 amine N–H bending
10 1708.93 aliphatic ketone C=O stretching
11 2854.65 alcohol O–H stretching
12 2922.16 carboxylic acid O–H stretching

The FT-IR analysis of the ethyl acetate extract of L. aspera exhibited characteristic peaks corresponding to various functional groups: S=O stretching of sulfoxide (1039.63/cm), C–O stretching of aliphatic ether (1163.08/cm), C–O stretching of alkyl aryl ether (1269.16/cm), O–H stretching of phenol (1375.25/cm), NO stretching of nitro compound (1514.12/cm), C=C stretching of α, β-unsaturated ketone (1610.56/cm), and CH stretching of alkane (2939.52/cm) was confirmed (Fig. 3, Table 4). In previous studies, FT-IR analysis revealed that the alkaloids exhibited NH stretching, phenols and flavonoids had OH stretching (Devi and Battu, 2019), saponins had C=O stretching (Bajad and Pardeshi, 2016), tannins possess C=C stretching (Marques, 2021). The outcomes of the current study revealed that dichloromethane and ethyl acetate extracts of L. aspera have alkaloids, flavonoids, phenols, saponins, and tannins, whereas the hexane extract of L. aspera showed the presence of alkaloids and tannins and these are in correlation with previous studies of Das et al. (2011), Vasudha et al. (2019).

Fig. 3.

Fig. 3

FTIR profile of ethyl acetate extract of L. aspera

Table 4.

Functional groups identified using FT-IR analysis of ethyl acetate extract of L. aspera

S. No. Peak Compound class Group
1 1039.63 sulfoxide S=O stretching
2 1163.08 aliphatic ether C–O stretching
3 1269.16 alkyl aryl ether C–O stretching
4 1375.25 phenol O–H stretching
5 1514.12 nitro compound N–O stretching
6 1610.56 unsaturated ketone C=C stretching of α, β-unsaturated ketone
7 2939.52 alkane C–H stretching

The GC-MS chromatogram of the hexane extract of L. aspera (Fig. 4) showed 19 peaks representing different phytoconstituents. Identification of these phytoconstituents was achieved by comparing their retention time (RT), peak area, peak height, and mass fragmentation spectra with known compounds in the National Institute of Standards and Technology (NIST) library (Table 5). Among these 19 compounds, dodecane,1,12-di (2-nitro 3-ethoxyphenoxy) emerged as the most abundant, constituting 24.159% of the peak area. Other major compounds included octadecanoic acid (22.634% peak area), octadic-9-enoic acid (22.231% peak area), 6-octadecynoic acid (22.037% peak area), 9-octadecenoic acid, methyl ester (21.784% peak area), and nhexadecanoic acid (20.509% peak area). The structures of the identified compounds are illustrated in Figure 5.

Fig. 4.

Fig. 4

GC-MS analysis of L. aspera hexane extract; the GC-MS analysis revealed the presence of various compound at different retention time

Table 5.

GC-MS analysis of L. aspera hexane extract

No. Retention time [min] PubChem CID Name of compound Molecular formula Molecular weight
1 20.509 985 n-hexadecanoic acid C16H32O2 256
2 21.78 5364509 9-octadecenoic acid, methyl ester C19H36O2 296
3 22.037 556781 6-octadecynoic acid C19H34O2 294
4 22.231 965 octadec-9-enoic acid C18H34O2 282
5 22.482 5281 octadecanoic acid C18H36O2 284
6 24.159 543867 dodecane,1,12-di(2-nitro3-ethoxyphenoxy) C2H4N2O8 532

Fig. 5.

Fig. 5

Structures of compounds identified in hexane extract of L. aspera. A) n-hexadecanoic acid, B) 9-octadecenoic acid, methyl ester, C) 6-octadecynoic acid, D) octadec-9-enoic acid, E) octadecanoic acid, F) dodecane, 1,12- di (2-nitro 3-ethoxyphenoxy)

Similarly, the GC-MS chromatogram of the dichloromethane extract of L. aspera showed 13 compounds (Fig. 6). The most abundant compounds included n-hexadecanoic acid (16.4% peak area, oleic acid (14.25% peak area), 17-octadecen-14-yn-1-ol (8.48% peak area), methylparaben (7.95% peak area), 6-octadecenoic acid (16.4% peak area), and 6-octadecenoic acid methyl ester, (Z) (2.65% peak area), and bicyclo [2.2.1] heptan-2-one, 5-bromo-1,7,7-trimethyl (2.22% peak area) (Table 6). The structures of the identified compounds are presented in Supplementary Figure S1.

Fig. 6.

Fig. 6

GC-MS analysis of L. aspera dichloromethane extract; the GC-MS analysis revealed the presence of various compound at different retention time

Table 6.

GC-MS analysis of L. aspera dichloromethane extract

No. Retention time [min] PubChem CID Name of compound Molecular formula Molecular weight
1 14.635 7456 methylparaben C 8 H 8 O 3 152
2 16.252 572870 bicyclo[2.2.1]heptan-2-one, 5-bromo-1,7,7-trimethyl- C10H15BrO 230
3 19.857 985 n-hexadecanoic acid C 16 H 32 O 2 256
4 21.22 5366845 6-octadecenoic acid, methyl ester, (Z)- C 19 H 36 O 2 296
5 21.634 445639 oleic acid C 18 H 34 O 2 282
6 21.919 28963 17-octadecen-14-yn-1-ol C 18 H 32 O 264
7 22.760 573804 2,2,4a,7a-tetramethyldecahydro-1H-cyclobuta[e]inden-5-ol C 15 H 26 O 222
8 25.054 440195 flavone 4'-OH,5-OH,7-di-o-glucoside C 27 H 30 O 15 594
9 23.636 5366009 2,6,10,15,19,23-hexamethyl-tetracosa-2,10,14,18,22-pentaene-6,7-diol C 30 H 52 O 2 444
10 18.485 10446 neophytadiene C 20 H 38 278
11 20.925 5281 octadecanoic acid C 18 H 36 O 2 284
12 18.280 91730075 (z)-valerenyl acetate C 17 H 26 O 2 262
13 26.358 11172 cyclononasiloxane C18H54O9Si9 666

Furthermore, the GC-MS chromatogram of the ethyl acetate extract of L. aspera displayed 19 compounds (Fig. 7). The most abundant compounds identified in this extract were methylparaben (28.74% peak area), phenol, 4-ethenyl-, acetate (14.78% peak area), n-hexadecanoic acid (8.57% peak area), 1,3,4,5-tetrahydroxycyclohexan (6.66% peak area), oleic acid (4.49% peak area), and cyclohex-2-enyl acetic acid (2.74% peak area) (Table 7). The structures of the identified compounds are depicted in Supplementary Figure S2.

Fig. 7.

Fig. 7

GC-MS analysis of L. aspera ethyl acetate extract; the GC-MS analysis revealed the presence of various compounds at different retention time

Table 7.

GC-MS analysis of L. aspera ethyl acetate extract

S.No Retention time [min] PubChem CID Name of compound Molecular formula Molecular weight
1 10.647 565060 8-azabicyclo[3.2.1]oct-6-en-3-one, 8-methyl C8H11NO 137
2 11.062 76731 phenol, 4-ethenyl-, acetate C 10 H 12 O 2 162
3 12.175 332 2-methoxy-4-vinyl phenol C 9 H 10 O 2 150
4 14.249 7456 methylparaben C 8 H 8 O 3 152
5 14.755 11947765 beta-D-glucopyranose, 1,6-anhydro C 6 H 10 O 5 162
6 16.410 1064 1,3,4,5-tetrahydroxycyclohexanecarboxylic acid C 7 H 12 O 6 192
7 17.713 11005 tetradecanoic acid C 14 H 28 O 2 228
8 18.473 10446 neophytadiene C 20 H 38 278
9 18.940 534620 2-octylcyclopropene-1-heptanol C 18 H 34 O 266
10 19.404 8181 hexadecanoic acid, methyl ester C 17 H 34 O 2 270
11 19.850 985 n-hexadecanoic acid C 16 H 32 O 2 256
12 21.632 445639 oleic acid C 18 H 34 O 2 282
13 21.884 227350 (cyclohex-2-enyl)acetic acid C 8 H 12 O 2 140
14 22.413 86056 bicyclo[4.1.0]heptan-3-ol, 3,7,7-trimethyl- C 10 H 18 O 154
15 22.752 538938 spiro[4.5]decan-7-one, 1,8-dimethyl-8,9-epoxy-4-isopropyl- C 15 H 24 O 2 236
16 24.455 21139795 androstan-17-ol, 2,3-epoxy-, (2.alpha.,3.alpha.,5.alpha.,17.beta.) C 19 H 30 O 2 290
17 7.298 753 glycerin C 3 H 8 O 3 92
18 8.932 6993818 1,2,3-propanetriol, 1-acetate C 5 H 10 O 4 134
19 25.615 91713331 adipic acid, dec-4-enyl isobutyl ester C 20 H 36 O 4 340

Certain phytochemical compounds, including methylparaben, neophytadiene, n-hexadecanoic acid and oleic acid, were identified in both the dichloromethane and ethyl acetate extracts of L. aspera. Neophytadiene has been previously associated with antioxidant, antimicrobial, antifungal, and anti-inflammatory properties (Raman et al., 2012). Oleic acid , known for its apoptotic activity, activates the expression of tumor suppressor genes, particularly p27, p21, and p53, especially in human esophageal cells (Moon et al., 2014).

Flavone 4′-OH,5-OH,7-di-o-glucoside, found in previous studies, has been linked to antioxidant and antimicrobial properties. For instance, El-Sharkawy et al. reported that this flavone, identified in the extract of Launaea nudicaulis, exhibited significant free radical scavenging activity (IC50 7.1g/l). Similarly, the extract of L. nudicaulis also exhibited good antimicrobial activity against both gram-positive and gram-negative bacteria, with a zone of inhibition ranging from 6.7 to 10.5 mm (El-Sharkawy et al., 2014). Octadecanoic acid is reputed to possess antibacterial, anticancer, and anti-histaminic properties (Khan and Javaid, 2022). Manivannan et al. (2017) have shown that octadecanoic acid induces apoptosis through DNA fragmentation in MCF7 and HePG2 cell lines.

Similar compounds identified in the current study have been reported in extracts of quinoa, known for its antifungal, antibacterial, antioxidant, and anticancer properties (Khan et al., 2021). Therefore, the findings from the current study, suggest that L. aspera possesses active phytochemical compounds with antioxidant, anticancer, and apoptotic activities.

MDA-MB-231 cells were subjected to treatment with hexane, dichloromethane, and ethyl acetate extracts of L. aspera, and their cytotoxic activity was evaluated through MTT assay. The outcomes indicated that the hexane extract did not impact the viability of MDA-MB-231 cells (results not shown). In contrast, dichloromethane treatment induced cell death with an IC50 of 5 μg/ml, and ethyl acetate treatment induced cell death with an IC50 of 3 μg/ml in MDA-MB-231 cells. Doxorubicin, used as a standard, exhibited an IC50 value of 1 μg/ml. Cells not exposed to any extract served as the control. The results of the cytotoxicity assay are presented in Figure 8.

Fig. 8.

Fig. 8

In vitro anticancer activity of L. aspera in MDA-MB-231 cells; the cytotoxicity analysis revealed IC50 as A) 1 μg/ml for doxorubicin, B) 5 μg/ml for Dichloromethane extract and C) 3 μg/ml for Ethyl acetate extract; values are shown as mean ± SD as the experiment was conducted in triplicates; *P < 0.05 are considered significant

Subsequently, cells were exposed to the IC50 concentrations of doxorubicin, dichloromethane, and ethyl acetate extracts and analyzed for morphological changes under a phasecontrast microscope. Cells treated with medium alone served as the control. The observations revealed that cells treated with dichloromethane and ethyl acetate extracts of L. aspera exhibited a round morphology, whereas, the control group and the doxorubicinreated group did not show any change in morphology. Moreover, more detached cells were observed in the extracttreated groups (Fig. 9).

Fig. 9.

Fig. 9

Cell biology studies of cells treated with A) control, B) doxorubicin, C) dichloromethane extract, D) ethyl acetate extract at their IC50 values (the images were taken at 10× magnification)

The current observations align with earlier studies conducted on L. aspera. Studies by Jayanthi et al. (2020) demonstrated that the ethanol extract from L. aspera flowers induced cytotoxicity in Ehrlich ascites carcinoma cells with an IC50 of 102.42 μg/ml under in vitro conditions. Similarly, reports by Augustine et al. (2014) showed that the ethyl acetate extract of L. aspera leaves induced cell death in Daltons Ascites Lymphoma (DAL) cells at an IC50 of 29.4 μg/ml.

The scratch assay was carried out to evaluate the effect of L. aspera extracts on inhibiting the migration of MDA-MB-231 cells under in vitro conditions. Cell migration plays a pivotal role in embryogenesis, wound healing, tissue development, and cancer metastasis (Olson et al., 2018). Understanding the mechanisms of cell migration is crucial for developing new therapeutics to control tumor invasion. The results of the scratch assay revealed that the number of cells migrating into the wound region was lower in cells treated with L. aspera extracts compared to the control group (Fig. 10). The percentage of cells migrating into the wound region in the control group was set as 100%. Based on this, the percentage of cells migrating into the wound was determined as 30.6% in the dichloromethane extract-treated group, whereas the percentage of migrated cells was 40% in the ethyl acetate extract-treated group (Fig. 11). The current observation indicates that the dichloromethane extract of L. aspera was more effective in preventing cell invasion compared to the ethyl acetate extract. Earlier studies have demonstrated that the methanol extract of L. aspera inhibited the migration of prostate cancer cells (PC3) at 0.25 mg/ml within 30 h (Mohan et al., 2017). In conclusion, it can be stated that dichloromethane and ethyl acetate extracts of L. aspera exhibit cell migration inhibitory properties.

Fig. 10.

Fig. 10

Cell migration analysis of L. aspera extracts; the figure shows A), B) cells that serves as control at 0 and 24 h, C), D) dichloromethane extract treated cells at 0 and 24 h, E) and F) ethyl acetate extract treated cells at 0 and 24 h; migration of cells inside the wound is observed at 24 h (images were taken at 5× magnification)

Fig. 11.

Fig. 11

Antimigratory effect of L. aspera extracts; the percentage of cells migrated in treated cells is less compared to control (the values show mean ± SD)

Conclusion

Based on the current study, it can be concluded that both dichloromethane and ethyl acetate extracts of L. aspera contain active phytochemical agents. These phytochemical compounds may contribute to the observed antiproliferative and anti-migratory activities of the plant extracts, in MDA-MB-231 cell tests. L. aspera could be a promising source for the development of therapeutic agents against triple-negative breast cancer. However, the specific compounds responsible for the antiproliferative and antimigratory activities have not been identified. Therefore, further studies are needed to identify and characterize these active compounds, providing insights into the effective management of TNBC.

Supplementary Material

Phytochemical characterization by GC-MS and in vitro evaluation of antiproliferative and antimigratory studies of Leucas aspera leaf extracts on MDA-MB-231 cell line
BTA-105-1-52457-s001.pdf (238.3KB, pdf)

Acknowledgments

The authors would like to express their sincere gratitude to the Dean, School of Life Sciences, B.S. Abdur Rahman Crescent Institute of Science and Technology for providing laboratory facilities.

Funding Statement

Funding The authors declare that no funding was received from any agency for this study.

Availability of data and materials

The data used and analyzed during the current study are available from the corresponding author upon reasonable request.

Author’s Contribution

Megasri S.: investigation, writing the original manuscript. Fazeela Mahaboob Begum S.M.: conceptualization, methodology, format analysis. Both authors wrote and edited the manuscript. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interest.

Ethics approval

Not applicable

Consent to participate

Not applicable

Consent to publish

Not applicable

References

  1. Al-Mahmood S., Sapiezynski J., Garbuzenko O.B., Minko T. (2018) Metastatic and triple-negative breast cancer: challenges and treatment options. Drug Deliv. Transl. Res. 8: 1483–1507. 10.1007/s13346-018-0551-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. American Cancer Society (2022) Treatment of triple-negative breast cancer. https://www.cancer.org/cancer/types/breastcancer/treatment/treatment-of-triple-negative.html
  3. Bajad P.N., Pardeshi A.B., (2016) Qualitative and quantitave analysis of saponin as bioactive sgent of Sapindus emarginatus. Int. J. Sci. Res. 5(10): 351–354. [Google Scholar]
  4. Begum S.M., Chitra K., Joseph B., Sundararajan R., Hemalatha S. (2018) Gelidiella acerosa inhibits lung cancer proliferation. BMC Complement Altern. Med. 18(1): 104. 10.1186/s12906-018-2165-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Centre for disease control and Prevention (2022) Triple-negative breast cancer. https://www.cdc.gov/cancer/breast/triple-negative.htm
  6. Chen Z., Wang X., Li X., Zhou Y., Chen K. (2021) Deep exploration of PARP inhibitors in breast cancer: monotherapy and combination therapy. J. Int. Med. Res. 49(2): 300060521991019. 10.1177/0300060521991019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cui W., Iwasa K., Tokuda H., Kashihara A., Mitani Y., Hasegawa T., Nishiyama Y., Moriyasu M., Nishino H., Hanaoka M., Mukai C., Takeda K. (2006) Potential cancer chemopreventive activity of simple isoquinolines, 1-benzylisoquinolines, and protoberberines. Phytochemistry 67: 70–79. 10.1016/j.phytochem.2005.10.007 [DOI] [PubMed] [Google Scholar]
  8. Das B.K., Das B., Arpita F.K., Morshed M.A., Uddin A., Bhattacherjee R., Hannan J.M.A. (2011) Phytochemical screening and antioxidant activity of Leucas aspera. Int. J. Pharma. Sci. Res. 2(7): 1746–1752. [Google Scholar]
  9. Desai A.G., Qazi G.N., Ganju R.K., El-Tamer M., Singh J., Saxena A.K., Bedi Y.S., Taneja S.C., Bhat H.K. (2008) Medicinal plants and cancer chemoprevention. Curr. Drug Metab. 9: 581–591. 10.2174/138920008785821657 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Devi D.R., Battu G.R. (2019) Qualitative phytochemical screening and ftir spectroscopic analysis of Grewia tilifolia (Vahl) leaf extracts. Int. J. Curr Pharm. Res. 11(4): 100–107. 10.22159/ijcpr.2019v11i4.34936 [DOI] [Google Scholar]
  11. Dubey A., Yadav P., Peeyush., Verma P., Kumar R. (2022) Investigation of proapoptotic potential of Ipomoea carnea leaf extract on nreast cancer cell line. J. Drug Deliv. Ther. 12(1): 51–55. 10.22270/jddt.v12i1.5172 [DOI] [Google Scholar]
  12. El-Sharkawy E.R., Ed-Dra A., Abdallah E.M. (2017) Phytochemical, antimicrobial and antioxidant properties of Launaea nudicaulis and Farsetia hamiltonii. Biol. Control. 31(2): 102–109. 10.18311/jbc/2017/15910 [DOI] [Google Scholar]
  13. Global Cancer Observatory (2021) https://gco.iarc.fr/today/home
  14. Hobani Y.H. (2022) Cytotoxicity of mahanimbine from curry leaves in human breast cancer cells (MCF-7) via mitochondrial apoptosis and anti-angiogenesis. Molecules 27(3): 971. 10.3390/molecules27030971 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. International Agency for research on Cancer (2021) Cancer today. https://gco.iarc.fr/today/fact-sheets-cancers
  16. Jayanthi M.K., Begum S.N., Ramu R. (2020) Evaluation of anticancer activity of ethanol extracts of Leucas aspera flower. Int. J. Green Pharm. 14(3): 257–264. [Google Scholar]
  17. John M.K.M., Harnly J., Luthria D. (2018) Influence of direct and sequential extraction methodology on metabolic profiling. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 1073: 34–42. 10.1016/j.jchromb.2017.12.005 [DOI] [PubMed] [Google Scholar]
  18. Khan I.H., Javaid A. (2022) Hexane soluble bioactive components of leaf extract of quinoa. J. Anim. Plant Sci. 32(2): 309–314. 10.36899/JAPS.2022.2.0461 [DOI] [Google Scholar]
  19. Khan N., Ali A., Qadir A., Ali A., Warsi M.H., Tahir A., Ali A. (2021) GC-MS analysis and antioxidant activity of Wrightia tinctoria R.Br. leaf extract. J. AOAC Int. 104: 1415–1419. 10.1093/jaoacint/qsab054 [DOI] [PubMed] [Google Scholar]
  20. Konappa N., Udayashankar A.C., Krishnamurthy S., Pradeep C.K., Chowdappa S., Jogaiah S. (2020) GC-MS analysis of phytoconstituents from Amomum nilgiricum and molecular docking interactions of bioactive serverogenin acetate with target proteins. Sci Rep. 10: 16438. 10.1038/s41598-020-73442-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kopustinskiene D.M., Jakstas V., Savickas A., Bernatoniene J. (2020) Flavonoids as anticancer agents. Nutrients 12(2): 457. 10.3390/nu12020457 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kumar A.R., Ramaswamy M. (2014) Phytochemical screening by FTIR spectroscopic analysis of leaf extracts of selected Indian medicinal plants. Int. J. Curr. Microbiol. App. Sci. 3(1): 395–406. [Google Scholar]
  23. Kumar K.E., James T.J. (2020) Antibacterial activity of Moringa oleifera and Leucas aspera flower extract against fish pathogens. J. Mar. Biol. Assoc. India. 61: 89–94. 10.6024/jmbai.2019.61.2.2111-14 [DOI] [Google Scholar]
  24. Kumar P., Aggarwal R. (2016) An overview of triple-negative breast cancer. Arch. Gynecol. Obstet. 293: 247–269. 10.1007/s00404-015-3859-y [DOI] [PubMed] [Google Scholar]
  25. Latha B., Rumaisa Y., Soumya C.K., Shahul S., Sadhiya N. (2013) Phytochemical studies on Leucas aspera. J. Chem. Pharm. Res. 5: 222–228. [Google Scholar]
  26. Lin K., Baritaki S., Vivarelli S., Falzone L., Scalisi A., Libra M., Bonavida B. (2022) The breast cancer protooncogenes HER2, BRCA1 and BRCA2 and their regulation by the iNOS/NOS2 axis. Antioxidants 11(6): 1195. 10.3390/antiox11061195 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Manivannan P., Muralitharan G., Balaji N.P. (2017) Prediction aided in vitro analysis of octa-decanoic acid from cyanobacterium Lyngbya sp. As a pro-apoptotic factor in eliciting antiinflammatory properties. Bioinformation 13(9): 301–306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Marques S.R.R., Barbosa Azevedo T.K., de Castilho A.R.F., Braga R.M., Pimenta A.S. (2021) Extraction, quantification, and ftir characterization of bark tannins of four forest species grown in northeast brazil. Rev. Árvore. 45. 10.1590/1806-908820210000041 [DOI] [Google Scholar]
  29. Mbele M., Hull R., Dlamini Z. (2017) African medicinal plants and their derivatives: Current efforts towards potential anti-cancer drugs. Exp. Mol. Pathol. 103: 121–134. 10.1016/j.yexmp.2017.08.002 [DOI] [PubMed] [Google Scholar]
  30. Mishra R., Dwivedi B., Gupta D. (2022) Physicochemical, phytochemical, qualitative HPTLC and antioxidant study of medicinal plant Leucas aspera. Trends Sci. 19: 5646–5646. 10.48048/tis.2022.5646 [DOI] [Google Scholar]
  31. Mohan A., Nair S.V., Lakshmanan V.K. (2017) Leucas aspera nanomedicine shows superior toxicity and cell migration retarded in prostate cancer cells. Appl. Biochem. Biotechnol. 181(4): 1388–1400. 10.1007/s12010-016-2291-5 [DOI] [PubMed] [Google Scholar]
  32. Moon H.S., Batirel S., Mantzoros C.S. (2014) Alpha linolenic acid oleic acid additively down-regulate malignant potential and positively cross-regulate AMPK/S6 axis in OE19 and OE33 esophageal cancer cells. Metabolism 63(11): 1447–1454. 10.1016/j.metabol.2014.07.009 [DOI] [PubMed] [Google Scholar]
  33. National Cancer Institute (2021) What is cancer? https://www.cancer.gov/about-cancer/understanding/what-is-cancer
  34. Nirmala K.A., Kanchana M. (2018) Leucas aspera – a review of its biological activity. Syst. Rev. Pharm. 9: 41–44. 10.5530/srp.2018.1.8 [DOI] [Google Scholar]
  35. Olson H.M., Nechiporuk A.V. (2018) Using zebrafish to study collective cell migration in development and disease. Front Cell Dev. Biol. 6: 83. 10.3389/fcell.2018.00083 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Polley MY.C., Leon-Ferre R.A., Leung S., Cheng A., Gao D., Sinnwell J., Lie H., Hillman D.W., Eyman-Casey A., Gilbert J.A., et al. (2021) A clinical calculator to predict disease outcomes in women with triple-negative breast cancer. Breast Cancer Res. Treat. 185: 557–566. 10.1007/s10549-020-06030-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Prajapati M.S., Patel J.B., Modi K., Shah M.B. (2010) Leucas aspera: A review. Pharmacogn. Rev. 4: 85–87. 10.4103/0973-7847.65330 [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Raman V.B., Samuel La., Saradhi P.M., Rao N.B., Krishna N.V., Sudhakar M., Radhakrishnan T.M. (2012) Antibacterial, antioxidant activity and GC-MS analysis of Eupatorium odoratum. Asian J. Pharm. Clin. Res. 5(2): 99–106. [Google Scholar]
  39. Sengodan S.K., Sreelatha K.H., Nadhan R., Srinivas P. (2018) Regulation of epithelial to mesenchymal transition by BRCA1 in breast cancer. Crit. Rev. Oncol. Hematol. 123: 74–82. 10.1016/j.critrevonc.2018.01.008 [DOI] [PubMed] [Google Scholar]
  40. Sharma S., Meher S., Tiwari S.P., Bhadran S. (2021) In vitro antimicrobial activity and phytochemical analysis of leaves, seeds, bark, flowers of Pongamia pinnata (Linn. Pierre) against human pathogens. Sys. Rev. Pharm. 12(4): 180–186. [Google Scholar]
  41. Vasudha K., Archana D., Mutyalamma B., Kishori B. (2019) Phytochemical screening, antimicrobial, and antioxidant activities of root and leaf extracts of Leucas aspera. Asian J. Pharm. Clin. Res. 12(3): 141–147. 10.22159/ajpcr.2019.v12i3.29085 [DOI] [Google Scholar]
  42. Wahba H.A., El-Hadaad H.A. (2015) Current approaches in treatment of triple-negative breast cancer. Cancer Biol. Med. 12: 106–116. 10.7497/j.issn.2095-3941.2015.0030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. World Health Organisation (2021) Breast cancer. https://www.who.int/news-room/fact-sheets/detail/breast-cancer
  44. Yildirim I., Kutlu T. (2015) Anticancer agents: saponin and tannin. Int. J. Biol. Chem. 9(6): 332–340. 10.3923/ijbc.2015.332.340 [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Phytochemical characterization by GC-MS and in vitro evaluation of antiproliferative and antimigratory studies of Leucas aspera leaf extracts on MDA-MB-231 cell line
BTA-105-1-52457-s001.pdf (238.3KB, pdf)

Data Availability Statement

The data used and analyzed during the current study are available from the corresponding author upon reasonable request.


Articles from BioTechnologia are provided here courtesy of Institute of Bioorganic Chemistry Polish Academy of Sciences

RESOURCES